E E Roughead1, K McGeechan, G P Sayer. 1. Quality Use of Medicines and Pharmacy Research Centre, School of Pharmaceutical Molecular and Biomedical Sciences, University of South Australia, North Terrace, Adelaide 5000, South Australia, Australia. libby.roughead@unisa.edu.au
Abstract
AIM: To determine the extent of prescribing of acid suppression agents associated with initiation of bisphosphonate therapy. METHODS: This was a case control study, performed within the General Practice Network, Australia. The main outcome measure was re-attendance within six weeks from index bisphosphonate prescription for acid supression agents. RESULTS: Of the bisphosphonate cases, 2.9%[95% confidence interval (CI) 1.8, 3.9] returned within 6 weeks for a prescription for proton pump inhibitor, histamine 2 receptor antagonist or antacid, compared with 0.9% of control patients (95% CI 0.5, 1.2). However, the bisphosphonate cases had significantly higher rates of previous use of nonsteroidal anti-inflammatory agents. After controlling for previous nonsteroidal anti-inflammatory drug use, the increased use of acid suppression agents was statistically significant, the odds ratio = 3.21 (95% CI 2.02, 5.11). CONCLUSION: Bisphosphonate use appears to be associated with increased use of acid suppressant agents within 6 weeks of first supply.
AIM: To determine the extent of prescribing of acid suppression agents associated with initiation of bisphosphonate therapy. METHODS: This was a case control study, performed within the General Practice Network, Australia. The main outcome measure was re-attendance within six weeks from index bisphosphonate prescription for acid supression agents. RESULTS: Of the bisphosphonate cases, 2.9%[95% confidence interval (CI) 1.8, 3.9] returned within 6 weeks for a prescription for proton pump inhibitor, histamine 2 receptor antagonist or antacid, compared with 0.9% of control patients (95% CI 0.5, 1.2). However, the bisphosphonate cases had significantly higher rates of previous use of nonsteroidal anti-inflammatory agents. After controlling for previous nonsteroidal anti-inflammatory drug use, the increased use of acid suppression agents was statistically significant, the odds ratio = 3.21 (95% CI 2.02, 5.11). CONCLUSION:Bisphosphonate use appears to be associated with increased use of acid suppressant agents within 6 weeks of first supply.
Authors: Hugh Taggart; Michael A Bolognese; Robert Lindsay; Mark P Ettinger; Henk Mulder; Robert G Josse; Anthony Roberts; Hartmut Zippel; Silvano Adami; Teresa F Ernst; Karen P Stevens Journal: Mayo Clin Proc Date: 2002-03 Impact factor: 7.616
Authors: Geoffrey P Sayer; Kevin McGeechan; Andrew Kemp; Alice Bhasale; Fiona Horn; Leigh Hendrie; Lisa Swan; Sharon Scahill Journal: Pharmacoepidemiol Drug Saf Date: 2003-09 Impact factor: 2.890
Authors: P C de Groen; D F Lubbe; L J Hirsch; A Daifotis; W Stephenson; D Freedholm; S Pryor-Tillotson; M J Seleznick; H Pinkas; K K Wang Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245
Authors: K A Colebatch Bpharm McLin Pharm; J Marley Md Mbchb; C Doecke; H Miles Bsc; A Gilbert Bpharm Phd Journal: Pharmacoepidemiol Drug Saf Date: 2000-11 Impact factor: 2.890